D.E. Shaw & Co
VRTX icon

D.E. Shaw & Co’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$8.94M Sell
20,081
-51,852
-72% -$23.1M 0.01% 1120
2025
Q1
$34.9M Sell
71,933
-193,751
-73% -$93.9M 0.03% 446
2024
Q4
$107M Buy
265,684
+127,276
+92% +$51.3M 0.08% 201
2024
Q3
$64.4M Sell
138,408
-31,655
-19% -$14.7M 0.06% 264
2024
Q2
$79.7M Sell
170,063
-185,395
-52% -$86.9M 0.07% 206
2024
Q1
$149M Buy
355,458
+142,477
+67% +$59.6M 0.13% 100
2023
Q4
$86.7M Sell
212,981
-44,012
-17% -$17.9M 0.08% 166
2023
Q3
$89.4M Buy
256,993
+5,235
+2% +$1.82M 0.09% 139
2023
Q2
$88.6M Buy
251,758
+46,826
+23% +$16.5M 0.09% 155
2023
Q1
$64.6M Buy
204,932
+94,399
+85% +$29.7M 0.07% 218
2022
Q4
$31.9M Sell
110,533
-7,720
-7% -$2.23M 0.04% 402
2022
Q3
$34.2M Sell
118,253
-160,491
-58% -$46.5M 0.04% 368
2022
Q2
$78.5M Sell
278,744
-465,504
-63% -$131M 0.09% 173
2022
Q1
$194M Sell
744,248
-277,075
-27% -$72.3M 0.18% 70
2021
Q4
$224M Sell
1,021,323
-693,311
-40% -$152M 0.19% 67
2021
Q3
$311M Buy
1,714,634
+937,619
+121% +$170M 0.28% 36
2021
Q2
$157M Buy
777,015
+230,391
+42% +$46.5M 0.14% 115
2021
Q1
$117M Sell
546,624
-327,724
-37% -$70.4M 0.11% 159
2020
Q4
$207M Buy
874,348
+523,210
+149% +$124M 0.18% 74
2020
Q3
$95.6M Buy
351,138
+203,308
+138% +$55.3M 0.1% 184
2020
Q2
$42.9M Sell
147,830
-149,357
-50% -$43.4M 0.05% 313
2020
Q1
$70.7M Sell
297,187
-76,786
-21% -$18.3M 0.11% 166
2019
Q4
$81.9M Sell
373,973
-324,695
-46% -$71.1M 0.09% 188
2019
Q3
$118M Sell
698,668
-171,241
-20% -$29M 0.15% 111
2019
Q2
$160M Sell
869,909
-133,320
-13% -$24.4M 0.2% 89
2019
Q1
$185M Sell
1,003,229
-165,372
-14% -$30.4M 0.24% 68
2018
Q4
$194M Sell
1,168,601
-96,755
-8% -$16M 0.27% 58
2018
Q3
$244M Buy
1,265,356
+163,766
+15% +$31.6M 0.29% 49
2018
Q2
$187M Buy
1,101,590
+142,529
+15% +$24.2M 0.24% 66
2018
Q1
$156M Buy
959,061
+539,411
+129% +$87.9M 0.21% 83
2017
Q4
$62.9M Buy
419,650
+95,561
+29% +$14.3M 0.09% 209
2017
Q3
$49.3M Sell
324,089
-484,897
-60% -$73.7M 0.08% 257
2017
Q2
$104M Buy
808,986
+234,501
+41% +$30.2M 0.17% 114
2017
Q1
$62.8M Sell
574,485
-63,098
-10% -$6.9M 0.11% 186
2016
Q4
$47M Buy
637,583
+189,572
+42% +$14M 0.08% 229
2016
Q3
$39.1M Sell
448,011
-528,039
-54% -$46.1M 0.07% 266
2016
Q2
$84M Sell
976,050
-170,285
-15% -$14.6M 0.15% 119
2016
Q1
$91.1M Buy
1,146,335
+483,811
+73% +$38.5M 0.16% 123
2015
Q4
$83.4M Buy
662,524
+284,371
+75% +$35.8M 0.12% 143
2015
Q3
$39.4M Sell
378,153
-421,934
-53% -$43.9M 0.06% 291
2015
Q2
$98.8M Sell
800,087
-316,944
-28% -$39.1M 0.15% 128
2015
Q1
$132M Buy
1,117,031
+106,572
+11% +$12.6M 0.2% 89
2014
Q4
$120M Buy
1,010,459
+582,438
+136% +$69.2M 0.15% 99
2014
Q3
$48.1M Sell
428,021
-496,004
-54% -$55.7M 0.06% 234
2014
Q2
$87.5M Sell
924,025
-973,774
-51% -$92.2M 0.12% 140
2014
Q1
$134M Buy
1,897,799
+1,175,459
+163% +$83.1M 0.19% 81
2013
Q4
$53.7M Buy
722,340
+488,938
+209% +$36.3M 0.07% 190
2013
Q3
$17.7M Sell
233,402
-72,115
-24% -$5.47M 0.03% 389
2013
Q2
$24.4M Buy
+305,517
New +$24.4M 0.05% 312